Clinical Trial Update: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199 [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to assess how ketoconazole affects the metabolism of venetoclax (ABT-199) in patients with Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Venclexta (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED